Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials

H Zhang, X Yue, Z Chen, C Liu, W Wu, N Zhang, Z Liu… - Molecular Cancer, 2023 - Springer
Despite centuries since the discovery and study of cancer, cancer is still a lethal and
intractable health issue worldwide. Cancer-associated fibroblasts (CAFs) have gained much …

What is new in cancer-associated fibroblast biomarkers?

Z Zhao, T Li, Y Yuan, Y Zhu - Cell Communication and Signaling, 2023 - Springer
The tumor microenvironment is one of the important drivers of tumor development. Cancer-
associated fibroblasts (CAFs) are a major component of the tumor stroma and actively …

Targeting CRAF kinase in anti-cancer therapy: progress and opportunities

P Wang, K Laster, X Jia, Z Dong, K Liu - Molecular Cancer, 2023 - Springer
The RAS/mitogen-activated protein kinase (MAPK) signaling cascade is commonly
dysregulated in human malignancies by processes driven by RAS or RAF oncogenes …

[HTML][HTML] Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous …

J Hu, AJ Lazar, D Ingram, WL Wang… - … for immunotherapy of …, 2024 - ncbi.nlm.nih.gov
Background The extracellular matrix (ECM) and cancer-associated fibroblasts (CAFs) play
major roles in tumor progression, metastasis, and the poor response of many solid tumors to …

Periostin secreted from podoplanin‐positive cancer‐associated fibroblasts promotes metastasis of gastric cancer by regulating cancer stem cells via AKT and YAP …

Z Zhao, Y Zhang, E Guo, Y Zhang… - Molecular …, 2023 - Wiley Online Library
Cancer‐associated fibroblasts (CAFs) are heterogeneous stromal cells present in the tumor
microenvironment (TME), which play a critical role in gastric cancer (GC) progression. Here …

The regulatory relationship between NAMPT and PD-L1 in cancer and identification of a dual-targeting inhibitor

Y Yang, Z Li, Y Wang, J Gao, Y Meng… - EMBO molecular …, 2024 - embopress.org
Cancer is a heterogeneous disease. Although both tumor metabolism and tumor immune
microenvironment are recognized as driving factors in tumorigenesis, the relationship …

[HTML][HTML] POSTN secretion by extracellular matrix cancer-associated fibroblasts (eCAFs) correlates with poor ICB response via macrophage chemotaxis activation of …

T You, H Tang, W Wu, J Gao, X Li, N Li, X Xu… - Aging and …, 2023 - ncbi.nlm.nih.gov
Immune checkpoint blockade (ICB) therapy has revolutionized cancer treatment, but its
clinical benefit is limited in advanced gastric cancer (GC). Cancer-associated fibroblasts …

CAR NK cell therapy for the treatment of metastatic melanoma: Potential & prospects

W Hibler, G Merlino, Y Yu - Cells, 2023 - mdpi.com
Melanoma is among the most lethal forms of cancer, accounting for 80% of deaths despite
comprising just 5% of skin cancer cases. Treatment options remain limited due to the genetic …

Bête noire of chemotherapy and targeted therapy: CAF-mediated resistance

P De, J Aske, R Sulaiman, N Dey - Cancers, 2022 - mdpi.com
Simple Summary Tumor cells struggle to survive following treatment. The struggle ends in
either of two ways. The drug combination used for the treatment blocks the proliferation of …

Monitoring melanoma patients on treatment reveals a distinct macrophage population driving targeted therapy resistance

J Vasilevska, PF Cheng, J Lehmann, E Ramelyte… - Cell Reports …, 2024 - cell.com
Resistance to targeted therapy remains a major clinical challenge in melanoma. To uncover
resistance mechanisms, we perform single-cell RNA sequencing on fine-needle aspirates …